Cargando…
Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients
BACKGROUND: The methylated septin 9 (mSEPT9) assay was the first blood-based test approved by the United States Food and Drug Administration as a colorectal screening test. However, the diagnostic and prognostic role of preoperative mSEPT9 for colorectal cancer (CRC) in Chinese patients is still unk...
Autores principales: | Yang, Xue, Xu, Zhi-Jie, Chen, Xi, Zeng, Shuang-Shuang, Qian, Long, Wei, Jie, Peng, Mei, Wang, Xiang, Liu, Wan-Li, Ma, Hong-Ying, Gong, Zhi-Cheng, Yan, Yuan-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506579/ https://www.ncbi.nlm.nih.gov/pubmed/31114136 http://dx.doi.org/10.3748/wjg.v25.i17.2099 |
Ejemplares similares
-
Diagnostic Value of Methylated Septin9 for Colorectal Cancer Screening: A Meta-Analysis
por: Yan, Shirong, et al.
Publicado: (2016) -
Diagnostic Value of Methylated Septin9 for Colorectal Cancer Detection
por: Xie, Li, et al.
Publicado: (2018) -
Screening and Prognostic Value of Methylated Septin9 and its Association With Clinicopathological and Molecular Characteristics in Colorectal Cancer
por: Sun, Jie, et al.
Publicado: (2021) -
Masters of asymmetry – lessons and perspectives from 50 years of septins
por: Spiliotis, Elias T., et al.
Publicado: (2020) -
Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study
por: Lu, Dong-cheng, et al.
Publicado: (2022)